• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Crinetics Pharmaceuticals, Inc. - Common Stock (NQ:CRNX)

84.72 +0.02 (+0.02%)
Streaming Delayed Price Updated: 12:17 PM EDT, Aug 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 413,341
Open 84.62
Bid (Size) 84.71 (400)
Ask (Size) 84.72 (400)
Prev. Close 84.70
Today's Range 84.61 - 84.73
52wk Range 28.73 - 84.71
Shares Outstanding 54,026,103
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Vertex Pharmaceuticals Just Hit an All-Time High. Here's Why the Biotech Stock Could Soar Even More ↗
August 14, 2026
The drugmaker should significantly mitigate its most important risk as it develops new products. 
Via The Motley Fool
News headline image
Halper Sadeh LLC is Investigating Whether BZH, ACA, SYNA, CRNX are Obtaining Fair Deals for their Shareholders
August 08, 2026
From Halper Sadeh LLC
Via GlobeNewswire

Performance

YTD
+81.3%
+81.3%
1 Month
+1.0%
+1.0%
3 Month
+144.1%
+144.1%
6 Month
+93.9%
+93.9%
1 Year
+184.9%
+184.9%

More News

Read More
News headline image
Could 1 Tiny Biotech Topple Vertex Pharmaceuticals' Cystic Fibrosis Empire? ↗
August 07, 2026
Via The Motley Fool
News headline image
Why Vertex Pharmaceuticals Stock Ticked Higher on Tuesday ↗
August 04, 2026
Via The Motley Fool
News headline image
Crinetics Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
August 03, 2026
From Crinetics Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Vertex Just Paid $10 Billion for Crinetics. Here's Why Viking Therapeutics Could Be the Next Big Pharma Takeover Target ↗
July 30, 2026
Via The Motley Fool
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: TriCo Bancshares (Nasdaq – TCBK), Twin Vee PowerCats Co. (Nasdaq -VEEE), Crinetics Pharmaceuticals, Inc. (Nasdaq – CRNX), Element Solutions Inc. (NYSE – ESI)
July 21, 2026
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Shareholder Alert: Ademi LLP investigates whether Crinetics Pharmaceuticals, Inc. is obtaining a Fair Price for Public Shareholders
July 21, 2026
From Ademi LLP
Via GlobeNewswire
News headline image
Vertex Pharmaceuticals Just Made a $10 Billion Acquisition Worth Watching ↗
July 19, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Halper Sadeh LLC is Investigating Whether TCBK, ESI, CRNX, SOLS are Obtaining Fair Deals for their Shareholders
July 16, 2026
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Halper Sadeh LLC is Investigating Whether ESI, CRNX, SOLS are Obtaining Fair Deals for their Shareholders
July 15, 2026
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: TriCo Bancshares (Nasdaq – TCBK), Twin Vee PowerCats Co. (Nasdaq -VEEE), Crinetics Pharmaceuticals, Inc. (Nasdaq – CRNX), Element Solutions Inc. (NYSE – ESI)
July 14, 2026
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Here's Why Vertex Was Willing to Pay a Premium of More Than 100% for Crinetics Pharmaceuticals ↗
July 14, 2026
Via The Motley Fool
News headline image
Does Vertex's Acquisition of Crinetics Pharmaceuticals Make the Stock a No-Brainer Buy? ↗
July 13, 2026
Via The Motley Fool
News headline image
Is This Biotech Stock a Buy Near Its 52-Week High? ↗
July 10, 2026
Via The Motley Fool
News headline image
Why This Pharmaceutical Stock Jumped Close to 100% This Week ↗
July 10, 2026
Via The Motley Fool
Topics Bonds
News headline image
Vertex Pharmaceuticals Just Made a $10 Billion Move. Is the Stock a Buy? ↗
July 10, 2026
Via The Motley Fool
Topics Intellectual Property
On Thursday, there are stocks with unusual volume. Let's take a look. ↗
July 09, 2026
Via Chartmill
News headline image
Here's How Much $1000 Invested In Crinetics Pharmaceuticals 5 Years Ago Would Be Worth Today ↗
July 08, 2026
Via Benzinga
News headline image
Halper Sadeh LLC is Investigating Whether CRNX, ESI, INVE, SLP are Obtaining Fair Deals for their Shareholders
July 08, 2026
From Halper Sadeh LLC
Via GlobeNewswire
The trading volume of these stocks is deviating from the norm in today's session. ↗
July 08, 2026
Via Chartmill
News headline image
Crinetics Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Crinetics Pharmaceuticals, Inc. - CRNX
July 08, 2026
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Vertex’s Crinetics Deal Balances Growth with Integration Risk ↗
July 08, 2026
Via MarketBeat
News headline image
Vertex Is Paying a 102% Premium to Acquire Crinetics for $10 Billion. Here's Whether the Deal Is Worth It. ↗
July 08, 2026
Via The Motley Fool
News headline image
Vertex Is Buying Crinetics for $10 Billion. Here's What Investors Need to Know. ↗
July 07, 2026
Via The Motley Fool
Topics Intellectual Property

Frequently Asked Questions

Is Crinetics Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Crinetics Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Crinetics Pharmaceuticals, Inc. - Common Stock trade on?
Crinetics Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Crinetics Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Crinetics Pharmaceuticals, Inc. - Common Stock is CRNX on the Nasdaq Stock Market
What is the current price of Crinetics Pharmaceuticals, Inc. - Common Stock?
The current price of Crinetics Pharmaceuticals, Inc. - Common Stock is 84.72
When was Crinetics Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Crinetics Pharmaceuticals, Inc. - Common Stock was at 08/17/26 12:17 PM ET
What is the market capitalization of Crinetics Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Crinetics Pharmaceuticals, Inc. - Common Stock is 4.58B
How many shares of Crinetics Pharmaceuticals, Inc. - Common Stock are outstanding?
Crinetics Pharmaceuticals, Inc. - Common Stock has 5B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap